Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death-Reference-Cited by-同舟云学术

Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death

Published:2021-07 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Jachs Mathias,Hartl Lukas,Simbrunner Benedikt,Bauer David,Paternostro Rafael,Scheiner Bernhard,Schwabl Philipp,Stättermayer Albert F.,Pinter Matthias,Eigenbauer Ernst,Quehenberger Peter,Trauner Michael,Reiberger Thomas^ORCID,Mandorfer Mattias

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference44 articles.

1. Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension;de Franchis;J Hepatol,2015

2. Hepatic venous pressure gradient response in non-selective beta-blocker treatment—is it worth measuring?;Mandorfer;Curr Hepatol Rep,2019

3. Beta adrenergic blockade and decompensated cirrhosis;Reiberger;J Hepatol,2017

4. Prevention of variceal bleeding and rebleeding by NSBB – a tailored approach;Jachs;Clin Liver Dis,2021

5. Short-term hemodynamic effects of beta-blockers influence survival of patients with decompensated cirrhosis;Alvarado-Tapias;J Hepatol,2020

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High histamine levels are associated with acute‐on‐chronic liver failure and liver‐related death in patients with advanced chronic liver disease;Liver International;2024-08-13

2. Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta;Journal of Hepatology;2024-08

3. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient;Journal of Hepatology;2024-05

4. Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers;Gut;2024-03-25

5. Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease;Alimentary Pharmacology & Therapeutics;2024-03-14